
|Videos|November 26, 2013
The Treatment of Hairy Cell Leukemia
Author(s)Jae Park, MD
Jae Park, MD, attending physician, Leukemia Service, Memorial Sloan-Kettering Cancer Center, comments on the treatment of patients with hairy cell leukemia.
Clinical Pearls
Jae Park, MD, attending physician, Leukemia Service, Memorial Sloan-Kettering Cancer Center, comments on the treatment of patients with hairy cell leukemia.
- Patients with hairy cell leukemia typically receive cladribine or pentostatin and experience a long remission
- Patients are able to respond again to cladribine or pentostatin following relapse
- There are limited options for those who have gone through many lines of therapy







































